{"slideshow_credits": null, "snippet": "Bacteria are quickly growing resistant to the antibiotics we have \u2014 but our model for making new drugs is broken. It\u2019s time for a fresh approach.", "abstract": "Op-Ed article by medical expert Carl F Nathan calls for a more open and cooperative approach to developing drugs to fight growing threat of antibiotic-resistant bacteria.", "section_name": "Opinion", "print_page": "27", "document_type": "article", "byline": {"person": [{"lastname": "NATHAN", "rank": 1, "firstname": "Carl", "role": "reported", "organization": "", "middlename": "F."}], "original": "By CARL F. NATHAN", "contributor": ""}, "web_url": "http://www.nytimes.com/2012/12/10/opinion/teaming-up-to-make-new-antibiotics.html", "lead_paragraph": "Bacteria are quickly growing resistant to the antibiotics we have \u2014 but our model for making new drugs is broken. It\u2019s time for a fresh approach.", "headline": {"seo": "Teaming Up to Make New Antibiotics", "main": "Let\u2019s Gang Up on Killer Bugs", "print_headline": "Let\u2019s Gang Up on Killer Bugs", "content_kicker": "Op-Ed Contributor", "kicker": "Op-Ed Contributor"}, "_id": "50c52f7a00315214fbb7e86e", "word_count": "908", "multimedia": [{"height": 126, "url": "images/2012/12/10/opinion/1208OPEDroh/1208OPEDroh-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2012/12/10/opinion/1208OPEDroh/1208OPEDroh-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 320, "url": "images/2012/12/10/opinion/1208OPEDroh/1208OPEDroh-articleLarge-v3.jpg", "legacy": {"xlarge": "images/2012/12/10/opinion/1208OPEDroh/1208OPEDroh-articleLarge-v3.jpg", "xlargewidth": "600", "xlargeheight": "320"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2012/12/10/opinion/1208OPEDroh/1208OPEDroh-thumbStandard.jpg", "legacy": {"thumbnail": "images/2012/12/10/opinion/1208OPEDroh/1208OPEDroh-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2012-12-10T00:00:00Z", "source": "The New York Times", "news_desk": "OpEd", "keywords": [{"value": "Antibiotics", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Bacteria", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Research", "name": "subject", "is_major": "N", "rank": "4"}, {"value": "GlaxoSmithKline PLC", "name": "organizations", "is_major": "N", "rank": "5"}, {"value": "Gates, Bill and Melinda, Foundation", "name": "organizations", "is_major": "N", "rank": "6"}], "blog": [], "subsection_name": null, "type_of_material": "Op-Ed"}